May 22, 2012

Drug maker Apricus Biosciences will receive regulatory guidance from the Food and Drug Administration in July that will contain feedback concerning the drug maker's plans to seek approval for a nail fungus treatment.

June 9, 2010

The Food and Drug Administration has approved Breckenridge Pharmaceutical’s generic version of a fungal infection...